Literature DB >> 3080051

Evidence of inherited urea cycle defect in a case of fatal valproate toxicity.

M Hjelm, L V de Silva, J W Seakins, V G Oberholzer, C J Rolles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3080051      PMCID： PMC1338974          DOI： 10.1136/bmj.292.6512.23

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Determination of the rate of urea synthesis from serial measurements of plasma urea concentration after an alanine load: theoretical and methodological aspects.

Authors:  D Geiseler; J D Kay; V G Oberholzer; J W Seakins; M Hjelm
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

2.  Conditions affecting the colorimetry of orotic acid and orotidine in urine.

Authors:  M L Harris; V G Oberholzer
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

3.  The renal origin of sodium valproate-induced hyperammonemia in fasting humans.

Authors:  J M Warter; C Brandt; C Marescaux; L Rumbach; G Micheletti; G Chabrier; J Krieger; M Imler
Journal:  Neurology       Date:  1983-09       Impact factor: 9.910
  3 in total
  9 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  Modelling amino acid metabolism.

Authors:  M Hjelm; J Seakins
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

3.  Carbamoylphosphate synthetase deficiency in an adult: deterioration due to administration of valproic acid.

Authors:  M Horiuchi; Y Imamura; N Nakamura; I Maruyama; T Saheki
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Authors:  I Matsuda; T Matsuura; A Nishiyori; S Komaki; R Hoshide; T Matsumoto; M Funakoshi; K Kiwaki; F Endo; A Hata; M Shimadzu; M Yoshino
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

Review 5.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

Review 6.  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.

Authors:  J R Stephens; R H Levy
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 7.  Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.

Authors:  M F B Silva; C C P Aires; P B M Luis; J P N Ruiter; L IJlst; M Duran; R J A Wanders; I Tavares de Almeida
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

8.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.

Authors:  Martin Uhl; Stefan Schwab; Thomas Efferth
Journal:  Front Oncol       Date:  2016-10-07       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.